Clinical Trial Update: Evaluation of Fractalkine and Its Receptor in Peri-implantitis [NA]

View source ↗

Summary

Clinical trial entry evaluating the role of Fractalkine and its receptor in peri-implantitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peri-implantitis

Drugs mentioned

• Fractalkine (CX3CL1) and CX3CR1 pathway modulators

Snippet

Sponsor: Kubilay BARIŞ | Conditions: Peri-implantitis | NA | Status: RECRUITING